Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N(6)-dimethylallyladenine, also known as isopentenyl adenine or IPADE, is a synthetic cytokinin belonging to the class of 6-alkylaminopurines. It acts primarily as a plant growth regulator and is widely used in agriculture and plant biotechnology to promote cell division, differentiation, and organ development. Its main physiological functions include stimulating callus formation, inducing sprouting, promoting axillary shoot growth in various fruit crops (such as apples and pears), increasing fruit set rate, improving yield, enhancing resistance to disease and cold stress in plants, and delaying senescence of leafy vegetables. The mechanism of action involves mimicking natural cytokinins by binding to cytokinin receptors in plants; it also has been shown experimentally to inhibit cyclin-dependent kinase 2 (CDK2), suggesting potential activity on ATP-binding proteins[1][10]. There are no approved pharmaceutical indications for human use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N(6)-dimethylallyladenine.